These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9257761)

  • 21. Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia.
    Jaruratanasirikul S; Sriwiriyajan S; Ingviya N
    J Pharm Pharmacol; 2002 Dec; 54(12):1693-6. PubMed ID: 12542901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetic profile of a new generation of parenteral cephalosporin.
    Rybak M
    Am J Med; 1996 Jun; 100(6A):39S-44S. PubMed ID: 8678096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients.
    Cheatham SC; Shea KM; Healy DP; Humphrey ML; Fleming MR; Wack MF; Smith DW; Sowinski KM; Kays MB
    Int J Antimicrob Agents; 2011 Jan; 37(1):46-50. PubMed ID: 21074370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs.
    Isert D; Klesel N; Limbert M; Markus A; Seibert G; Schrinner E
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():31-7. PubMed ID: 1601754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.
    Lakings DB; Novak E; Friis JM; Lunan CM; Paxton LM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):271-7. PubMed ID: 3717932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics change of cefepime after Shuanghuanglian injection administration in subjects with the renal damage.
    Chen H; Min J; Li W; Zhao W; Mi S; Wang N; Zhu C
    Drug Chem Toxicol; 2016; 39(2):129-36. PubMed ID: 26108148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of cefepime during continuous venovenous hemodiafiltration.
    Allaouchiche B; Breilh D; Jaumain H; Gaillard B; Renard S; Saux MC
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2424-7. PubMed ID: 9371344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic-based ticarcillin/clavulanic acid dose recommendations for infants and children.
    Reed MD; Yamashita TS; Blumer JL
    J Clin Pharmacol; 1995 Jul; 35(7):658-65. PubMed ID: 7560245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs.
    Gardner SY; Papich MG
    J Vet Pharmacol Ther; 2001 Jun; 24(3):187-92. PubMed ID: 11442796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of pharmacokinetic interaction between cefepime and amikacin in humans.
    Barbhaiya RH; Knupp CA; Pfeffer M; Pittman KA
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1382-6. PubMed ID: 1510431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens.
    Rhodes NJ; Grove ME; Kiel PJ; O'Donnell JN; Whited LK; Rose DT; Jones DR; Scheetz MH
    Int J Antimicrob Agents; 2017 Sep; 50(3):482-486. PubMed ID: 28668694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of endotoxin induced fever on the pharmacokinetics of intramuscularly administered cefepime in rabbits.
    Goudah A; Mouneir SM; Shim JH; Abd El-Aty AM
    J Vet Sci; 2006 Jun; 7(2):151-5. PubMed ID: 16645340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Patel A; Chavan R; Yeole R; Friedland HD; Bhatia A
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic population study to describe cefepime lung concentrations.
    Breilh D; Saux MC; Delaisement C; Fratta A; Ducint D; Velly JF; Couraud L
    Pulm Pharmacol Ther; 2001; 14(2):69-74. PubMed ID: 11273786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-proportional pharmacokinetics of cefepime in rats.
    Brindley CJ; Brodie RR; Cook SC; Oldfield PR; Chasseaud LF; Barbhaiya RH
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():9-14. PubMed ID: 1820942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous administration of cefepime.
    Walker P; Neuhauser MN; Tam VH; Willey JS; Palmer JL; Bruera E; Prince RA
    J Pain Symptom Manage; 2005 Aug; 30(2):170-4. PubMed ID: 16125032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Halstenson CE; Opsahl JA; Pittman KA
    Drug Metab Dispos; 1991; 19(1):68-73. PubMed ID: 1673424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of age on the pharmacokinetics of single dose ceftiofur sodium administered intramuscularly or intravenously to cattle.
    Brown SA; Chester ST; Robb EJ
    J Vet Pharmacol Ther; 1996 Feb; 19(1):32-8. PubMed ID: 8992023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and tissue penetration of cefepime.
    Nye KJ; Shi YG; Andrews JM; Wise R
    J Antimicrob Chemother; 1989 Jul; 24(1):23-8. PubMed ID: 2777727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.